Memphis Pharmaceuticals & Chemical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Memphis Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP288.5M and total debt of EGP143.3M, which brings its debt-to-equity ratio to 49.7%. Its total assets and total liabilities are EGP1.3B and EGP1.0B respectively. Memphis Pharmaceuticals & Chemical Industries's EBIT is EGP309.1M making its interest coverage ratio -4.5. It has cash and short-term investments of EGP612.0M.
Key information
49.7%
Debt to equity ratio
ج.م143.29m
Debt
| Interest coverage ratio | -4.5x |
| Cash | ج.م611.96m |
| Equity | ج.م288.51m |
| Total liabilities | ج.م1.04b |
| Total assets | ج.م1.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MPCI's short term assets (EGP1.2B) exceed its short term liabilities (EGP930.4M).
Long Term Liabilities: MPCI's short term assets (EGP1.2B) exceed its long term liabilities (EGP112.0M).
Debt to Equity History and Analysis
Debt Level: MPCI has more cash than its total debt.
Reducing Debt: MPCI had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: MPCI's debt is well covered by operating cash flow (38.9%).
Interest Coverage: MPCI earns more interest than it pays, so coverage of interest payments is not a concern.